| Literature DB >> 33511866 |
Song Y Park1, Coley Doolittle-Amieva1, Yasman Moshiri1, Tomoko Akaike1, Upendra Parvathaneni2, Shailender Bhatia3, Lisa C Zaba4, Paul Nghiem1,2.
Abstract
Merkel cell carcinoma (MCC) is an aggressive skin cancer associated with a high risk of local recurrence and distant metastasis. Optimal care of this potentially life-threatening cancer is critical but challenging because: physicians are often unfamiliar with its management due to rarity, and MCC management remains controversial, in part because it is rapidly evolving across multiple specialties. While guidelines offer a broad overview of management, they are often not sufficient when making decisions for individual patients. Herein, we present a literature review as well as practical approaches adopted at our institutions for staging, surveillance and therapy of MCC. Each of these areas are discussed in light of how they can be appropriately customized for prevalent but challenging situations. We also provide representative examples of MCC patient scenarios and how they were managed by a multidisciplinary team to identify suitable evidence-based, individualized treatment plans.Entities:
Keywords: Merkel cell carcinoma; customized treatment; imaging; immunotherapy; multidisciplinary management; radiotherapy; surgery; surveillance
Year: 2021 PMID: 33511866 DOI: 10.2217/fon-2020-1036
Source DB: PubMed Journal: Future Oncol ISSN: 1479-6694 Impact factor: 3.404